Adverse prognostic impact of KIT mutations in childhood CBF-AML: the results of the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05 trial

Affiliations

• ¹ Department of Pediatrics, Kyoto University, Kyoto, Japan.
• ² Department of Hematology/Oncology, Gunma Children's Medical Center, Shibukawa, Japan.
• ³ Department of Pediatrics, Okayama University, Okayama, Japan.
• ⁴ Clinical Research Center, National Hospital Organization, Nagoya Medical Center, Nagoya, Japan.
• ⁵ Clinical Research Center, National Center for Child Health and Development, Tokyo, Japan.
• ⁶ Human Health Sciences, Kyoto University, Kyoto, Japan.
• ⁷ Department of Pediatrics, Fukuoka-Higashi Medical Center, National Hospital Organization, Koga, Japan.
• ⁸ Department of Pediatrics, St Marianna University School of Medicine, Kawasaki, Japan.
• ⁹ Division of Leukemia and Lymphoma, Children's Cancer Center, National Center for Child Health and Development, Tokyo, Japan.
• ¹⁰ Department of Pediatrics, Shiga University of Medical Science, Otsu, Japan.
• ¹¹ Department of Pediatrics, National Hospital Organization, Osaka Medical Center, Osaka, Japan.
• ¹² Department of Pharmacoepidemiology, Kyoto University, Kyoto, Japan.